Osmond D G, Batten S J
Am J Anat. 1984 Jul;170(3):349-65. doi: 10.1002/aja.1001700310.
The role of mammalian bone marrow in generating surface IgM (sIgM)-bearing B lymphocytes is reviewed. Precursor cells in the marrow give rise to large, rapidly dividing cells bearing free cytoplasmic mu chains (c mu). The progeny of the large c mu+ cells form a population of small, nondividing c mu+ cells that mature into small lymphocytes, progressively expressing sIgM and other B-cell surface membrane components. Newly formed sIgM+ cells soon migrate through the bloodstream to the spleen and other lymphoid tissues, where they may die after a short lifespan or be activated to produce antibody molecules. The large-scale lymphocytopoiesis in the bone marrow thus maintains a population of rapidly renewed virgin B lymphocytes in the peripheral lymphoid tissues. This process continuously creates and selects B cell clones with the wide range of antibody specificities necessary to mediate primary humoral immune responses through postnatal life. A technique for perfusing radiolabeled anti-IgM antibodies in young mice has now permitted sIgM+ cells to be detected radioautographically in histological preparations of bone marrow under the electron microscope. Small sIgM+ lymphocytes are situated either singly or in small groups throughout the extravascular hemopoietic compartment of the bone marrow, often near sinusoid walls adjacent to late erythroblasts and reticular cells. Some regional concentrations of sIgM+ cells are apparent. sIgM+ cells also appear in transit through the sinusoidal endothelium and are markedly concentrated in the lumen of some sinusoids. Intrasinusoidal sIgM+ small lymphocytes have high densities of sIgM and long microvilli, on which sIgM molecules are concentrated. These studies reveal the localization and cell associations of specifically identified sIgM+ small lymphocytes in the extravascular marrow compartment and suggest that these cells may also undergo a transient intravascular storage and maturation phase. Use of this in vivo immunolabeling technique to detect other cell-surface markers may further elucidate the microenvironmental basis of B lymphocyte genesis in the bone marrow.
本文综述了哺乳动物骨髓在产生携带表面免疫球蛋白M(sIgM)的B淋巴细胞中的作用。骨髓中的前体细胞产生大量快速分裂的细胞,这些细胞带有游离的细胞质μ链(cμ)。大型cμ+细胞的后代形成一群小型、不分裂的cμ+细胞,它们成熟为小淋巴细胞,逐渐表达sIgM和其他B细胞表面膜成分。新形成的sIgM+细胞很快通过血液循环迁移到脾脏和其他淋巴组织,在那里它们可能在短寿命后死亡,或者被激活产生抗体分子。因此,骨髓中的大规模淋巴细胞生成维持了外周淋巴组织中快速更新的原始B淋巴细胞群体。这个过程不断产生并选择具有广泛抗体特异性的B细胞克隆,这些特异性是介导出生后原发性体液免疫反应所必需的。一种在幼鼠中灌注放射性标记抗IgM抗体的技术,现在已使在电子显微镜下的骨髓组织学制剂中通过放射自显影检测到sIgM+细胞成为可能。小型sIgM+淋巴细胞单个或成小群地分布在骨髓的血管外造血区,常常靠近与晚期成红细胞和网状细胞相邻的窦壁。sIgM+细胞有一些区域集中现象。sIgM+细胞也出现在通过窦内皮的过程中,并且在一些窦的管腔中明显集中。窦内的sIgM+小淋巴细胞具有高密度的sIgM和长微绒毛,sIgM分子集中在这些微绒毛上。这些研究揭示了血管外骨髓区中特异性鉴定的sIgM+小淋巴细胞的定位和细胞关联,并表明这些细胞可能也经历一个短暂的血管内储存和成熟阶段。使用这种体内免疫标记技术检测其他细胞表面标志物,可能会进一步阐明骨髓中B淋巴细胞发生的微环境基础。